SPECIALTY PHARMACY

Share This Page

Specialty Pharmacy

Specialty pharmacy focuses on high cost, high touch medication therapy for patients with complex disease states. Medications in specialty pharmacy range from oral to cutting edge injectable and biologic products. The disease states treated range from cancer, multiple sclerosis and rheumatoid arthritis to rare genetic conditions.  

A specialty pharmacist may work in a variety of practice settings. Some pharmacists in this practice area work in pharmacies dedicated to only products that are considered specialty medications. In this setting, pharmacists may work in a variety of areas including dispensing, medication therapy management, patient advocacy and therapy compliance. Some pharmacists work in institutional or health system settings and may be involved with the patients therapy from in-patient to ambulatory care sites. Other pharmacists work in more traditional retail settings and either focus on certain specialty disease states at their practice sites or work with an affiliated specialty pharmacy provider to dispense these complex medications.  

SPECIALTY COVERAGE
October 07, 2016
October 07, 2016
**
MORE
September 26, 2016
September 26, 2016
Thrifty White Pharmacy announced Friday that it has received specialty pharmacy accreditation from URAC. "URAC accreditation validates our...
Thrifty White Pharmacy announced Friday that it has received specialty pharmacy accreditation from URAC. "URAC accreditation validates our comprehensive specialty pharmacy program," said Jeremy Faulks, director of specialty pharmacy at Thrifty White.
MORE
September 26, 2016
September 26, 2016
FDA has said that draft guidance on how an interchangeable biosimilar will be defined should come out by the end of 2016, but the just-released user...
FDA has said that draft guidance on how an interchangeable biosimilar will be defined should come out by the end of 2016, but the just-released user fee reauthorization commitment letter states the draft will publish sometime before the end of 2017.
MORE